The China regulatory and compliance practice in Latham & Watkins LLP's Beijing office acts for multinational companies and financial institutions facing challenging investigations and enforcement actions. The team routinely drafts anti-corruption policies, compliance plans and procedures, and assists with transactional due diligence so as to mitigate potential Foreign Corrupt Practices Act (FCPA) and corruption risks. Hui Xu is experienced in multi-jurisdictional investigations involving the FCPA, China’s bribery legislation and financial crimes. Xu’s track record further includes negotiating settlements with both US and China regulators. Sean Wu also assists companies with investigations.
Legal 500 Editorial commentary
Key clients
- Sinovac Biotech
- AO Smith Corporation
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Hui Xu
Other key lawyers
Sean Wu
